DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $366,442 | -11.7% | 1,584 | -5.3% | 0.08% | -20.0% |
| Q3 2023 | $414,825 | +5.1% | 1,672 | +1.7% | 0.10% | +11.8% |
| Q2 2023 | $394,560 | -4.8% | 1,644 | 0.0% | 0.08% | -10.5% |
| Q1 2023 | $414,354 | +94285.9% | 1,644 | -0.6% | 0.10% | -5.0% |
| Q4 2022 | $439 | -99.9% | 1,654 | 0.0% | 0.10% | -6.5% |
| Q3 2022 | $428,000 | +1.9% | 1,654 | 0.0% | 0.11% | +11.5% |
| Q2 2022 | $420,000 | -13.4% | 1,654 | 0.0% | 0.10% | +2.1% |
| Q1 2022 | $485,000 | -11.2% | 1,654 | -0.4% | 0.09% | -5.1% |
| Q4 2021 | $546,000 | +8.1% | 1,660 | 0.0% | 0.10% | +2.1% |
| Q3 2021 | $505,000 | +11.5% | 1,660 | -1.5% | 0.10% | +11.5% |
| Q2 2021 | $453,000 | +18.3% | 1,686 | -0.9% | 0.09% | +13.0% |
| Q1 2021 | $383,000 | -3.3% | 1,702 | -4.5% | 0.08% | -7.2% |
| Q4 2020 | $396,000 | +9.4% | 1,783 | +6.0% | 0.08% | -3.5% |
| Q3 2020 | $362,000 | +21.9% | 1,682 | 0.0% | 0.09% | +10.3% |
| Q2 2020 | $297,000 | +27.5% | 1,682 | 0.0% | 0.08% | +9.9% |
| Q1 2020 | $233,000 | -9.7% | 1,682 | 0.0% | 0.07% | +20.3% |
| Q4 2019 | $258,000 | +11.2% | 1,682 | +4.8% | 0.06% | +5.4% |
| Q3 2019 | $232,000 | -0.4% | 1,605 | -1.8% | 0.06% | +3.7% |
| Q2 2019 | $233,000 | +12.6% | 1,634 | +4.5% | 0.05% | +10.2% |
| Q1 2019 | $207,000 | -38.8% | 1,564 | -49.7% | 0.05% | -34.7% |
| Q3 2018 | $338,000 | -22.7% | 3,111 | -29.8% | 0.08% | -28.6% |
| Q2 2018 | $437,000 | -6.8% | 4,433 | -7.4% | 0.10% | -6.2% |
| Q1 2018 | $469,000 | -47.2% | 4,787 | -50.0% | 0.11% | -42.3% |
| Q4 2017 | $889,000 | +7.9% | 9,575 | -0.3% | 0.19% | +3.2% |
| Q3 2017 | $824,000 | -3.4% | 9,604 | -5.0% | 0.19% | -5.1% |
| Q2 2017 | $853,000 | -13.4% | 10,108 | -12.3% | 0.20% | -13.5% |
| Q1 2017 | $985,000 | +12.1% | 11,527 | +2.1% | 0.23% | +10.6% |
| Q4 2016 | $879,000 | -4.1% | 11,295 | -3.4% | 0.21% | -4.6% |
| Q3 2016 | $917,000 | -57.8% | 11,688 | -45.6% | 0.22% | -57.9% |
| Q2 2016 | $2,171,000 | +2.3% | 21,502 | -3.9% | 0.52% | +5.3% |
| Q1 2016 | $2,122,000 | -5.3% | 22,366 | -7.3% | 0.49% | -5.4% |
| Q4 2015 | $2,241,000 | -11.4% | 24,135 | -18.7% | 0.52% | -15.9% |
| Q3 2015 | $2,529,000 | +3.4% | 29,675 | +3.8% | 0.62% | +14.7% |
| Q2 2015 | $2,447,000 | -4.3% | 28,594 | -5.1% | 0.54% | +2.3% |
| Q1 2015 | $2,558,000 | -1.3% | 30,136 | -0.3% | 0.52% | +1.0% |
| Q4 2014 | $2,591,000 | +11.0% | 30,231 | -1.6% | 0.52% | +7.5% |
| Q3 2014 | $2,335,000 | -15.1% | 30,731 | -12.0% | 0.48% | -11.4% |
| Q2 2014 | $2,749,000 | +4.0% | 34,906 | -0.9% | 0.54% | +0.2% |
| Q1 2014 | $2,642,000 | -0.1% | 35,231 | +2.9% | 0.54% | -0.5% |
| Q4 2013 | $2,644,000 | +10.8% | 34,241 | -0.6% | 0.55% | +5.4% |
| Q3 2013 | $2,387,000 | +10.2% | 34,436 | +0.6% | 0.52% | +7.5% |
| Q2 2013 | $2,166,000 | – | 34,216 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |